Moderate  ||| S:0 E:9 ||| JJ
ethanol  ||| S:9 E:17 ||| JJ
administration  ||| S:17 E:32 ||| NN
accentuates  ||| S:32 E:44 ||| FW
cardiomyocyte  ||| S:44 E:58 ||| FW
contractile  ||| S:58 E:70 ||| FW
dysfunction  ||| S:70 E:82 ||| FW
and  ||| S:82 E:86 ||| CC
mitochondrial  ||| S:86 E:100 ||| JJ
injury  ||| S:100 E:107 ||| NN
in  ||| S:107 E:110 ||| IN
high  ||| S:110 E:115 ||| JJ
fat  ||| S:115 E:119 ||| JJ
diet-induced  ||| S:119 E:132 ||| JJ
obesity  ||| S:132 E:140 ||| JJ
Light  ||| S:140 E:146 ||| NN
to  ||| S:146 E:149 ||| TO
moderate  ||| S:149 E:158 ||| JJ
drinking  ||| S:158 E:167 ||| NN
confers  ||| S:167 E:175 ||| VBZ
cardioprotection  ||| S:175 E:192 ||| VBN
although  ||| S:192 E:201 ||| IN
it  ||| S:201 E:204 ||| PRP
remains  ||| S:204 E:212 ||| VBZ
unclear  ||| S:212 E:220 ||| JJ
with  ||| S:220 E:225 ||| IN
regards  ||| S:225 E:233 ||| VBG
to  ||| S:233 E:236 ||| TO
the  ||| S:236 E:240 ||| DT
role  ||| S:240 E:245 ||| NN
of  ||| S:245 E:248 ||| IN
moderate  ||| S:248 E:257 ||| JJ
drinking  ||| S:257 E:266 ||| NN
on  ||| S:266 E:269 ||| IN
cardiac  ||| S:269 E:277 ||| JJ
function  ||| S:277 E:286 ||| NN
in  ||| S:286 E:289 ||| IN
obesity ||| S:289 E:296 ||| NN
.  ||| S:296 E:298 ||| .
This  ||| S:298 E:303 ||| DT
study  ||| S:303 E:309 ||| NN
was  ||| S:309 E:313 ||| VBD
designed  ||| S:313 E:322 ||| VBN
to  ||| S:322 E:325 ||| TO
examine  ||| S:325 E:333 ||| VB
the  ||| S:333 E:337 ||| DT
impact  ||| S:337 E:344 ||| NN
of  ||| S:344 E:347 ||| IN
moderate  ||| S:347 E:356 ||| JJ
ethanol  ||| S:356 E:364 ||| JJ
intake  ||| S:364 E:371 ||| NN
on  ||| S:371 E:374 ||| IN
myocardial  ||| S:374 E:385 ||| JJ
function  ||| S:385 E:394 ||| NN
in  ||| S:394 E:397 ||| IN
high  ||| S:397 E:402 ||| JJ
fat  ||| S:402 E:406 ||| JJ
diet  ||| S:406 E:411 ||| NN
intake-induced  ||| S:411 E:426 ||| JJ
obesity  ||| S:426 E:434 ||| NN
and  ||| S:434 E:438 ||| CC
the  ||| S:438 E:442 ||| DT
mechanism ||| S:442 E:451 ||| NN
( ||| S:451 E:452 ||| -LRB-
s ||| S:452 E:453 ||| LS
)  ||| S:453 E:455 ||| -RRB-
involved  ||| S:455 E:464 ||| VBN
with  ||| S:464 E:469 ||| IN
a  ||| S:469 E:471 ||| DT
focus  ||| S:471 E:477 ||| NN
on  ||| S:477 E:480 ||| IN
mitochondrial  ||| S:480 E:494 ||| JJ
integrity ||| S:494 E:503 ||| NN
.  ||| S:503 E:505 ||| .
C57BL ||| S:505 E:510 ||| CD
/ ||| S:510 E:511 ||| CD
6  ||| S:511 E:513 ||| CD
mice  ||| S:513 E:518 ||| NNS
were  ||| S:518 E:523 ||| VBD
fed  ||| S:523 E:527 ||| VBN
low  ||| S:527 E:531 ||| JJ
or  ||| S:531 E:534 ||| CC
high  ||| S:534 E:539 ||| JJ
fat  ||| S:539 E:543 ||| JJ
diet  ||| S:543 E:548 ||| NN
for  ||| S:548 E:552 ||| IN
16  ||| S:552 E:555 ||| CD
weeks  ||| S:555 E:561 ||| NNS
prior  ||| S:561 E:567 ||| RB
to  ||| S:567 E:570 ||| TO
ethanol  ||| S:570 E:578 ||| VB
challenge  ||| S:578 E:588 ||| NN
( ||| S:588 E:589 ||| -LRB-
1g ||| S:589 E:591 ||| FW
/ ||| S:591 E:592 ||| FW
kg ||| S:592 E:594 ||| FW
/ ||| S:594 E:595 ||| FW
d  ||| S:595 E:597 ||| FW
for  ||| S:597 E:601 ||| IN
3  ||| S:601 E:603 ||| CD
days ||| S:603 E:607 ||| NNS
) ||| S:607 E:608 ||| -RRB-
.  ||| S:608 E:610 ||| .
Cardiac  ||| S:610 E:618 ||| JJ
contractile  ||| S:618 E:630 ||| JJ
function ||| S:630 E:638 ||| NN
,  ||| S:638 E:640 ||| ,
intracellular  ||| S:640 E:654 ||| VBG
Ca ||| S:654 E:656 ||| NNP
( ||| S:656 E:657 ||| -LRB-
2+ ||| S:657 E:659 ||| NNP
)  ||| S:659 E:661 ||| -RRB-
homeostasis ||| S:661 E:672 ||| NN
,  ||| S:672 E:674 ||| ,
myocardial  ||| S:674 E:685 ||| JJ
histology ||| S:685 E:694 ||| NN
,  ||| S:694 E:696 ||| ,
and  ||| S:696 E:700 ||| CC
mitochondrial  ||| S:700 E:714 ||| JJ
integrity  ||| S:714 E:724 ||| NN
[ ||| S:724 E:725 ||| -LRB-
aconitase  ||| S:725 E:735 ||| JJ
activity  ||| S:735 E:744 ||| NN
and  ||| S:744 E:748 ||| CC
the  ||| S:748 E:752 ||| DT
mitochondrial  ||| S:752 E:766 ||| JJ
proteins  ||| S:766 E:775 ||| NNS
SOD1 ||| S:775 E:779 ||| RB
,  ||| S:779 E:781 ||| ,
UCP-2  ||| S:781 E:787 ||| NNP
and  ||| S:787 E:791 ||| CC
PPARγ  ||| S:791 E:797 ||| JJ
coactivator  ||| S:797 E:809 ||| JJ
1α  ||| S:809 E:812 ||| NNP
( ||| S:812 E:813 ||| -LRB-
PGC-1α ||| S:813 E:819 ||| NNP
) ||| S:819 E:820 ||| -RRB-
]  ||| S:820 E:822 ||| -RRB-
were  ||| S:822 E:827 ||| VBD
assessed  ||| S:827 E:836 ||| VBN
24h  ||| S:836 E:840 ||| CD
after  ||| S:840 E:846 ||| IN
the  ||| S:846 E:850 ||| DT
final  ||| S:850 E:856 ||| JJ
ethanol  ||| S:856 E:864 ||| JJ
challenge ||| S:864 E:873 ||| NN
.  ||| S:873 E:875 ||| .
Fat  ||| S:875 E:879 ||| FW
diet  ||| S:879 E:884 ||| FW
intake  ||| S:884 E:891 ||| FW
compromised  ||| S:891 E:903 ||| FW
cardiomyocyte  ||| S:903 E:917 ||| FW
contractile  ||| S:917 E:929 ||| FW
and  ||| S:929 E:933 ||| CC
intracellular  ||| S:933 E:947 ||| JJ
Ca ||| S:947 E:949 ||| NNP
( ||| S:949 E:950 ||| -LRB-
2+ ||| S:950 E:952 ||| NNP
)  ||| S:952 E:954 ||| -RRB-
properties  ||| S:954 E:965 ||| NNS
( ||| S:965 E:966 ||| -LRB-
depressed  ||| S:966 E:976 ||| JJ
peak  ||| S:976 E:981 ||| NN
shortening  ||| S:981 E:992 ||| NN
and  ||| S:992 E:996 ||| CC
maximal  ||| S:996 E:1004 ||| JJ
velocities  ||| S:1004 E:1015 ||| NN
of  ||| S:1015 E:1018 ||| IN
shortening ||| S:1018 E:1028 ||| CD
/ ||| S:1028 E:1029 ||| CD
relengthening ||| S:1029 E:1042 ||| NN
,  ||| S:1042 E:1044 ||| ,
prolonged  ||| S:1044 E:1054 ||| JJ
duration  ||| S:1054 E:1063 ||| NN
of  ||| S:1063 E:1066 ||| IN
relengthening ||| S:1066 E:1079 ||| NN
,  ||| S:1079 E:1081 ||| ,
dampened  ||| S:1081 E:1090 ||| FW
intracellular  ||| S:1090 E:1104 ||| FW
Ca ||| S:1104 E:1106 ||| FW
( ||| S:1106 E:1107 ||| -LRB-
2+ ||| S:1107 E:1109 ||| NNP
)  ||| S:1109 E:1111 ||| -RRB-
rise  ||| S:1111 E:1116 ||| NN
and  ||| S:1116 E:1120 ||| CC
clearance  ||| S:1120 E:1130 ||| NN
without  ||| S:1130 E:1138 ||| IN
affecting  ||| S:1138 E:1148 ||| VBG
duration  ||| S:1148 E:1157 ||| NN
of  ||| S:1157 E:1160 ||| IN
shortening ||| S:1160 E:1170 ||| CD
) ||| S:1170 E:1171 ||| -RRB-
.  ||| S:1171 E:1173 ||| .
Although  ||| S:1173 E:1182 ||| IN
moderate  ||| S:1182 E:1191 ||| JJ
ethanol  ||| S:1191 E:1199 ||| NNS
challenge  ||| S:1199 E:1209 ||| VBP
failed  ||| S:1209 E:1216 ||| VBN
to  ||| S:1216 E:1219 ||| TO
alter  ||| S:1219 E:1225 ||| VB
cardiomyocyte  ||| S:1225 E:1239 ||| JJ
mechanical  ||| S:1239 E:1250 ||| JJ
property  ||| S:1250 E:1259 ||| NN
under  ||| S:1259 E:1265 ||| IN
low  ||| S:1265 E:1269 ||| JJ
fat  ||| S:1269 E:1273 ||| JJ
diet  ||| S:1273 E:1278 ||| NN
intake ||| S:1278 E:1284 ||| NN
,  ||| S:1284 E:1286 ||| ,
it  ||| S:1286 E:1289 ||| PRP
accentuated  ||| S:1289 E:1301 ||| VBP
high  ||| S:1301 E:1306 ||| JJ
fat  ||| S:1306 E:1310 ||| JJ
diet  ||| S:1310 E:1315 ||| NN
intake-induced  ||| S:1315 E:1330 ||| JJ
changes  ||| S:1330 E:1338 ||| NNS
in  ||| S:1338 E:1341 ||| IN
cardiomyocyte  ||| S:1341 E:1355 ||| JJ
contractile  ||| S:1355 E:1367 ||| JJ
function  ||| S:1367 E:1376 ||| NN
and  ||| S:1376 E:1380 ||| CC
intracellular  ||| S:1380 E:1394 ||| JJ
Ca ||| S:1394 E:1396 ||| NNP
( ||| S:1396 E:1397 ||| -LRB-
2+ ||| S:1397 E:1399 ||| NNP
)  ||| S:1399 E:1401 ||| -RRB-
handling ||| S:1401 E:1409 ||| NN
.  ||| S:1409 E:1411 ||| .
Moderate  ||| S:1411 E:1420 ||| JJ
ethanol  ||| S:1420 E:1428 ||| NNS
challenge  ||| S:1428 E:1438 ||| VBP
failed  ||| S:1438 E:1445 ||| VBN
to  ||| S:1445 E:1448 ||| TO
affect  ||| S:1448 E:1455 ||| VB
fat  ||| S:1455 E:1459 ||| JJ
diet  ||| S:1459 E:1464 ||| NN
intake-induced  ||| S:1464 E:1479 ||| JJ
cardiac  ||| S:1479 E:1487 ||| JJ
hypertrophy  ||| S:1487 E:1499 ||| NN
as  ||| S:1499 E:1502 ||| IN
evidenced  ||| S:1502 E:1512 ||| VBN
by  ||| S:1512 E:1515 ||| IN
H ||| S:1515 E:1516 ||| NNP
& ||| S:1516 E:1517 ||| CC
E  ||| S:1517 E:1519 ||| NN
staining ||| S:1519 E:1527 ||| NN
.  ||| S:1527 E:1529 ||| .
High  ||| S:1529 E:1534 ||| JJ
fat  ||| S:1534 E:1538 ||| JJ
diet  ||| S:1538 E:1543 ||| NN
intake  ||| S:1543 E:1550 ||| VBZ
reduced  ||| S:1550 E:1558 ||| VBN
myocardial  ||| S:1558 E:1569 ||| JJ
aconitase  ||| S:1569 E:1579 ||| JJ
activity ||| S:1579 E:1587 ||| NN
,  ||| S:1587 E:1589 ||| ,
downregulated  ||| S:1589 E:1603 ||| JJ
levels  ||| S:1603 E:1610 ||| NNS
of  ||| S:1610 E:1613 ||| IN
mitochondrial  ||| S:1613 E:1627 ||| JJ
protein  ||| S:1627 E:1635 ||| NN
UCP-2 ||| S:1635 E:1640 ||| NN
,  ||| S:1640 E:1642 ||| ,
PGC-1α ||| S:1642 E:1648 ||| NNP
,  ||| S:1648 E:1650 ||| ,
SOD1  ||| S:1650 E:1655 ||| NNP
and  ||| S:1655 E:1659 ||| CC
interrupted  ||| S:1659 E:1671 ||| JJ
intracellular  ||| S:1671 E:1685 ||| JJ
Ca ||| S:1685 E:1687 ||| NNP
( ||| S:1687 E:1688 ||| -LRB-
2+ ||| S:1688 E:1690 ||| NNP
)  ||| S:1690 E:1692 ||| -RRB-
regulatory  ||| S:1692 E:1703 ||| JJ
proteins ||| S:1703 E:1711 ||| NNS
,  ||| S:1711 E:1713 ||| ,
the  ||| S:1713 E:1717 ||| DT
effect  ||| S:1717 E:1724 ||| NN
of  ||| S:1724 E:1727 ||| IN
which  ||| S:1727 E:1733 ||| WDT
was  ||| S:1733 E:1737 ||| VBD
augmented  ||| S:1737 E:1747 ||| VBN
by  ||| S:1747 E:1750 ||| IN
moderate  ||| S:1750 E:1759 ||| JJ
ethanol  ||| S:1759 E:1767 ||| JJ
challenge ||| S:1767 E:1776 ||| NN
.  ||| S:1776 E:1778 ||| .
Neither  ||| S:1778 E:1786 ||| DT
high  ||| S:1786 E:1791 ||| JJ
fat  ||| S:1791 E:1795 ||| JJ
diet  ||| S:1795 E:1800 ||| NN
intake  ||| S:1800 E:1807 ||| NN
nor  ||| S:1807 E:1811 ||| CC
moderate  ||| S:1811 E:1820 ||| JJ
ethanol  ||| S:1820 E:1828 ||| NNS
challenge  ||| S:1828 E:1838 ||| VBP
affected  ||| S:1838 E:1847 ||| VBN
protein  ||| S:1847 E:1855 ||| NN
or  ||| S:1855 E:1858 ||| CC
mRNA  ||| S:1858 E:1863 ||| JJ
levels  ||| S:1863 E:1870 ||| NNS
as  ||| S:1870 E:1873 ||| IN
well  ||| S:1873 E:1878 ||| RB
as  ||| S:1878 E:1881 ||| IN
phosphorylation  ||| S:1881 E:1897 ||| NN
of  ||| S:1897 E:1900 ||| IN
Akt  ||| S:1900 E:1904 ||| NNP
and  ||| S:1904 E:1908 ||| CC
GSK3β  ||| S:1908 E:1914 ||| CD
in  ||| S:1914 E:1917 ||| IN
mouse  ||| S:1917 E:1923 ||| NN
hearts ||| S:1923 E:1929 ||| NNS
.  ||| S:1929 E:1931 ||| .
Taken  ||| S:1931 E:1937 ||| VBN
together ||| S:1937 E:1945 ||| RB
,  ||| S:1945 E:1947 ||| ,
our  ||| S:1947 E:1951 ||| PRP$
data  ||| S:1951 E:1956 ||| NNS
revealed  ||| S:1956 E:1965 ||| VBD
that  ||| S:1965 E:1970 ||| DT
moderate  ||| S:1970 E:1979 ||| JJ
ethanol  ||| S:1979 E:1987 ||| JJ
challenge  ||| S:1987 E:1997 ||| NN
accentuated  ||| S:1997 E:2009 ||| VBZ
high  ||| S:2009 E:2014 ||| JJ
fat  ||| S:2014 E:2018 ||| JJ
diet-induced  ||| S:2018 E:2031 ||| JJ
cardiac  ||| S:2031 E:2039 ||| JJ
contractile  ||| S:2039 E:2051 ||| NN
and  ||| S:2051 E:2055 ||| CC
intracellular  ||| S:2055 E:2069 ||| JJ
Ca ||| S:2069 E:2071 ||| NNP
( ||| S:2071 E:2072 ||| -LRB-
2+ ||| S:2072 E:2074 ||| NNP
)  ||| S:2074 E:2076 ||| -RRB-
anomalies  ||| S:2076 E:2086 ||| VBZ
as  ||| S:2086 E:2089 ||| RB
well  ||| S:2089 E:2094 ||| RB
as  ||| S:2094 E:2097 ||| IN
mitochondrial  ||| S:2097 E:2111 ||| JJ
injury ||| S:2111 E:2117 ||| NN
.  ||| S:2117 E:2119 ||| .
